| Literature DB >> 25117709 |
Hannelore Maes1, Anna Kuchnio2, Aleksandar Peric3, Stijn Moens2, Kris Nys1, Katrien De Bock2, Annelies Quaegebeur2, Sandra Schoors2, Maria Georgiadou2, Jasper Wouters4, Stefan Vinckier2, Hugo Vankelecom5, Marjan Garmyn6, Anne-Clémence Vion7, Freddy Radtke8, Chantal Boulanger7, Holger Gerhardt9, Elisabetta Dejana10, Mieke Dewerchin2, Bart Ghesquière2, Wim Annaert3, Patrizia Agostinis11, Peter Carmeliet2.
Abstract
Chloroquine (CQ) has been evaluated as an autophagy blocker for cancer treatment, but it is unknown if it acts solely by inhibiting cancer cell autophagy. We report that CQ reduced tumor growth but improved the tumor milieu. By normalizing tumor vessel structure and function and increasing perfusion, CQ reduced hypoxia, cancer cell invasion, and metastasis, while improving chemotherapy delivery and response. Inhibiting autophagy in cancer cells or endothelial cells (ECs) failed to induce such effects. CQ's vessel normalization activity relied mainly on alterations of endosomal Notch1 trafficking and signaling in ECs and was abrogated by Notch1 deletion in ECs in vivo. Thus, autophagy-independent vessel normalization by CQ restrains tumor invasion and metastasis while improving chemotherapy, supporting the use of CQ for anticancer treatment.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25117709 DOI: 10.1016/j.ccr.2014.06.025
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743